Article
ctDNA as a Cancer Biomarker: A Broad Overview
2020-06-21
Abstract excerpt
Circulating tumor DNA (ctDNA) in fluids has gained attention because ctDNA seems to identify tumor-specific abnormalities, which could be used for diagnosis, follow-up of treatment, and prognosis: the so-called liquid biopsy. Liquid biopsy is a minimally invasive approach and presents the sum of ctDNA from primary and secondary tumor sites. It has been possible not only to quantify the amount of ctDNA but also to...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 07e7c3f9-a46b-5bbe-a96c-1c32af744374
- DOI
- 10.20944/preprints202006.0263.v1